NCT02566668View on ClinicalTrials.gov

Immune Interactions in Severe Asthma

CompletedOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 22, 2022

Study Completion Date

August 22, 2024

Conditions
Asthma
Interventions
OTHER

1 year Observational Follow-up

Approximately 12 months after research bronchoscopy, subjects will return for follow-up visit.

Trial Locations (1)

15213

University of Pittsburgh Asthma Institute at UPMC, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT02566668 - Immune Interactions in Severe Asthma | Biotech Hunter | Biotech Hunter